{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:39:07Z","timestamp":1792726747268,"version":"4.5.0"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Globally, more than 10 million people developed active tuberculosis (TB), with 1.4 million deaths in 2020. In addition, the emergence of drug-resistant strains in many regions of the world threatens national TB control programs. This requires an understanding of host-pathogen interactions and finding novel treatments including host-directed therapies (HDTs) is of utter importance to tackle the TB epidemic. <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (Mtb), the causative agent for TB, mainly infects the lungs causing inflammatory processes leading to immune activation and the development and formation of granulomas. During TB disease progression, the mononuclear inflammatory cell infiltrates which form the central structure of granulomas undergo cellular changes to form epithelioid cells, multinucleated giant cells and foamy macrophages. Granulomas further contain neutrophils, NK cells, dendritic cells and an outer layer composed of T and B lymphocytes and fibroblasts. This complex granulomatous host response can be modulated by Mtb to induce pathological changes damaging host lung tissues ultimately benefiting the persistence and survival of Mtb within host macrophages. The development of cavities is likely to enhance inter-host transmission and caseum could facilitate the dissemination of Mtb to other organs inducing disease progression. This review explores host targets and molecular pathways in the inflammatory granuloma host immune response that may be beneficial as target candidates for HDTs against TB.<\/jats:p>","DOI":"10.3389\/fimmu.2021.733853","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:54:08Z","timestamp":1634770448000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Reto","family":"Guler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mumin","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solima","family":"Sabeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongani","family":"Motaung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj P.","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Thienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Brombacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report 2020","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1628","article-title":"Human Tuberculous Granulomas Induce Peripheral Lymphoid Follicle-Like Structures to Orchestrate Local Host Defence in the Lung","volume":"204","author":"Ulrichs","year":"2004","journal-title":"J Pathol: A\u00a0J\u00a0Pathol Soc Great Britain Ireland"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri3211","article-title":"Revisiting the Role of the Granuloma in Tuberculosis","volume":"12","author":"Ramakrishnan","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00098","article-title":"Modeling the Mycobacterium Tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease","volume":"4","author":"Guirado","year":"2013","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/path.1906","article-title":"New Insights Into the Function of Granulomas in Human Tuberculosis","volume":"208","author":"Ulrichs","year":"2006","journal-title":"J Pathol: A J Pathol Soc Great Britain Ireland"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0490-8","article-title":"CD8 T Cells and Mycobacterium Tuberculosis Infection","volume":"37","author":"Lin","year":"2015","journal-title":"Semin Immunopathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"139127","DOI":"10.1155\/2012\/139127","article-title":"The Tuberculous Granuloma: An Unsuccessful Host Defence Mechanism Providing a Safety Shelter for the Bacteria","volume":"2012","author":"Silva Miranda","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1900086","DOI":"10.1002\/bies.201900086","article-title":"Granulomatous Inflammation in Tuberculosis and Sarcoidosis: Does the Lymphatic System Contribute to Disease","volume":"41","author":"Patterson","year":"2019","journal-title":"Bioessays"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1006974","DOI":"10.1371\/journal.ppat.1006974","article-title":"Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis","volume":"14","author":"Xu","year":"2018","journal-title":"PloS Pathog"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201110-1769OC","article-title":"Doxycycline and HIV Infection Suppress Tuberculosis-Induced Matrix Metalloproteinases","volume":"185","author":"Walker","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e26254","DOI":"10.1371\/journal.pone.0026254","article-title":"Evidence for Oxidative Stress and Defective Antioxidant Response in Guinea Pigs With Tuberculosis","volume":"6","author":"Palanisamy","year":"2011","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e39680","DOI":"10.1371\/journal.pone.0039680","article-title":"Adjunctive TNF Inhibition With Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas","volume":"7","author":"Skerry","year":"2012","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e30749","DOI":"10.1371\/journal.pone.0030749","article-title":"Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy With FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model","volume":"7","author":"Maiga","year":"2012","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajpath.2011.03.039","article-title":"Phosphodiesterase-4 Inhibition Combined With Isoniazid Treatment of Rabbits With Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology","volume":"179","author":"Subbian","year":"2011","journal-title":"Am J Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.01.015","article-title":"Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model","volume":"4","author":"Subbian","year":"2016","journal-title":"EBioMedicine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaj1789","article-title":"Host Sirtuin 1 Regulates Mycobacterial Immunopathogenesis and Represents a Therapeutic Target Against Tuberculosis","volume":"2","author":"Cheng","year":"2017","journal-title":"Sci Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e55415","DOI":"10.7554\/eLife.55415","article-title":"Host Sirtuin 2 as an Immunotherapeutic Target Against Tuberculosis","volume":"9","author":"Bhaskar","year":"2020","journal-title":"Elife"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404137","article-title":"Functional Drug Screening Reveals Anticonvulsants as Enhancers of mTOR-Independent Autophagic Killing of Mycobacterium Tuberculosis Through Inositol Depletion","volume":"7","author":"Schiebler","year":"2015","journal-title":"EMBO Mol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00798","article-title":"A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis","volume":"9","author":"Kroesen","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as Adjunct Antituberculosis Therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci Trans Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/CM9.0000000000000394","article-title":"Calcitriol Enhances Pyrazinamide Treatment of Murine Tuberculosis","volume":"132","author":"Zhang","year":"2019","journal-title":"Chin Med J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.10.020","article-title":"Inhalable Poly (Lactic-Co-Glycolic Acid)(PLGA) Microparticles Encapsulating All-Trans-Retinoic Acid (ATRA) as a Host-Directed, Adjunctive Treatment for Mycobacterium Tuberculosis Infection","volume":"134","author":"O\u2019Connor","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.12.2696","article-title":"Retinoic Acid Therapy Attenuates the Severity of Tuberculosis While Altering Lymphocyte and Macrophage Numbers and Cytokine Expression in Rats Infected With Mycobacterium Tuberculosis","volume":"137","author":"Yamada","year":"2007","journal-title":"J Nutr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711373114","article-title":"In Vivo Inhibition of Tryptophan Catabolism Reorganizes the Tuberculoma and Augments Immune-Mediated Control of Mycobacterium Tuberculosis","volume":"115","author":"Gautam","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04313.x","article-title":"Induction of \u03b2-Defensins by L-Isoleucine as Novel Immunotherapy in Experimental Murine Tuberculosis","volume":"164","author":"Rivas-Santiago","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.041954","article-title":"FX11 Limits Mycobacterium Tuberculosis Growth and Potentiates Bactericidal Activity of Isoniazid Through Host-Directed Activity","volume":"13","author":"Krishnamoorthy","year":"2020","journal-title":"Dis Models Mech"},{"key":"B28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-Directed Therapy of Tuberculosis Based on Interleukin-1 and Type I Interferon Crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00891","article-title":"Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques","volume":"11","author":"Winchell","year":"2020","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit550","article-title":"Statin Therapy Reduces the Mycobacterium Tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation","volume":"209","author":"Parihar","year":"2014","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz517","article-title":"Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice","volume":"221","author":"Dutta","year":"2020","journal-title":"J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1086\/430621","article-title":"Differential Organization of the Local Immune Response in Patients With Active Cavitary Tuberculosis or With Nonprogressive Tuberculoma","volume":"192","author":"Ulrichs","year":"2005","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-011-8229-7","article-title":"Latent Tuberculosis: What the Host \u201cSees\u201d","volume":"50","author":"Gideon","year":"2011","journal-title":"Immunol Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms","volume":"78","author":"Dutta","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in Tuberculosis Pathology, Microenvironments and Therapeutic Responses","volume":"264","author":"Lenaerts","year":"2015","journal-title":"Immunol Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00595-10","article-title":"Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs Against Mycobacterium Tuberculosis","volume":"55","author":"De Groote","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/0300985817705177","article-title":"Microbial Offense vs Host Defense: Who Controls the TB Granuloma","volume":"55","author":"Martinot","year":"2018","journal-title":"Vet Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/0470846526.ch9","article-title":"Susceptibility to Tuberculosis as a Complex Genetic Trait: Analysis Using Recombinant Congenic Strains of Mice","volume":"217","author":"Kramnik","year":"1998","journal-title":"Novartis Found Symp"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00217-12","article-title":"Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB\/FeJ Mice for Testing of Drugs Against Mycobacterium Tuberculosis","volume":"56","author":"Driver","year":"2012","journal-title":"Antimicrobial Agents Chemother"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00887-06","article-title":"Mycobacterium Marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and is Moderated by Adaptive Immunity","volume":"74","author":"Swaim","year":"2006","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6111-1_13","article-title":"Looking Within the Zebrafish to Understand the Tuberculous Granuloma","volume":"783","author":"Ramakrishnan","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e39123","DOI":"10.7554\/eLife.39123","article-title":"Potentiation of P2RX7 as a Host-Directed Strategy for Control of Mycobacterial Infection","volume":"8","author":"Matty","year":"2019","journal-title":"Elife"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e18632","DOI":"10.1371\/journal.pone.0018632","article-title":"Experimental Tuberculosis in the Wistar Rat: A Model for Protective Immunity and Control of Infection","volume":"6","author":"Singhal","year":"2011","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tube.2007.12.003","article-title":"Disseminated Disease Severity as a Measure of Virulence of Mycobacterium Tuberculosis in the Guinea Pig Model","volume":"88","author":"Palanisamy","year":"2008","journal-title":"Tuberc (Edinb)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00276-07","article-title":"Location of Persisting Mycobacteria in a Guinea Pig Model of Tuberculosis Revealed by R207910","volume":"51","author":"Lenaerts","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00531-12","article-title":"Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis Using [(1)(8)F]2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography","volume":"56","author":"Via","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B47","doi-asserted-by":"publisher","first-page":"110016","DOI":"10.1098\/rsob.110016","article-title":"Chronic Pulmonary Cavitary Tuberculosis in Rabbits: A Failed Host Immune Response","volume":"1","author":"Subbian","year":"2011","journal-title":"Open Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.10.6004-6011.2003","article-title":"Different Strains of Mycobacterium Tuberculosis Cause Various Spectrums of Disease in the Rabbit Model of Tuberculosis","volume":"71","author":"Manabe","year":"2003","journal-title":"Infect Immun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2013.05.006","article-title":"Experimental Aerosol Mycobacterium Bovis Model of Infection in Goats","volume":"93","author":"Gonzalez-Juarrero","year":"2013","journal-title":"Tuberc (Edinb)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpa.2010.12.006","article-title":"Microscopical and Immunological Features of Tuberculoid Granulomata and Cavitary Pulmonary Tuberculosis in Naturally Infected Goats","volume":"145","author":"Sanchez","year":"2011","journal-title":"J Comp Pathol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e10030","DOI":"10.1371\/journal.pone.0010030","article-title":"Granuloma Encapsulation is a Key Factor for Containing Tuberculosis Infection in Minipigs","volume":"5","author":"Gil","year":"2010","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00632-13","article-title":"Differential Virulence and Disease Progression Following Mycobacterium Tuberculosis Complex Infection of the Common Marmoset (Callithrix Jacchus)","volume":"81","author":"Via","year":"2013","journal-title":"Infect Immun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0684.2012.00536.x","article-title":"The non-Human Primate Model of Tuberculosis","volume":"41","author":"Kaushal","year":"2012","journal-title":"J Med Primatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e53657","DOI":"10.1371\/journal.pone.0053657","article-title":"Human Granuloma In Vitro Model, for TB Dormancy and Resuscitation","volume":"8","author":"Kapoor","year":"2013","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2004.00371.x","article-title":"An In Vitro Dual Model of Mycobacterial Granulomas to Investigate the Molecular Interactions Between Mycobacteria and Human Host Cells","volume":"6","author":"Puissegur","year":"2004","journal-title":"Cell Microbiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e53084","DOI":"10.3791\/53084","article-title":"A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium Tuberculosis Infection","author":"Braian","year":"2015","journal-title":"JoVE (J Vis Exp)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.013854","article-title":"Modeling Mycobacterium Tuberculosis Early Granuloma Formation in Experimental Human Lung Tissue","volume":"7","author":"Parasa","year":"2014","journal-title":"Dis Models Mech"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424563112","article-title":"Anti-Vascular Endothelial Growth Factor Treatment Normalizes Tuberculosis Granuloma Vasculature and Improves Small Molecule Delivery","volume":"112","author":"Datta","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1371\/journal.pbio.0020367","article-title":"Tuberculous Granuloma Formation is Enhanced by a Mycobacterium Virulence Determinant","volume":"2","author":"Volkman","year":"2004","journal-title":"PloS Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2008.11.014","article-title":"The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection","volume":"136","author":"Davis","year":"2009","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.1179663","article-title":"Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein With Host Epithelium","volume":"327","author":"Volkman","year":"2010","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02048-05","article-title":"Role for Matrix Metalloproteinase 9 in Granuloma Formation During Pulmonary Mycobacterium Tuberculosis Infection","volume":"74","author":"Taylor","year":"2006","journal-title":"Infect Immun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.6.4223","article-title":"Identification of a Matrix-Degrading Phenotype in Human Tuberculosis In Vitro and In Vivo","volume":"166","author":"Price","year":"2001","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00127807","article-title":"High MMP-9 Activity Characterises Pleural Tuberculosis Correlating With Granuloma Formation","volume":"33","author":"Sheen","year":"2009","journal-title":"Eur Respir J"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1159\/000084048","article-title":"Expression of Matrix Metalloproteinase-9 in Pleural Effusions of Tuberculosis and Lung Cancer","volume":"72","author":"Park","year":"2005","journal-title":"Respiration"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/iep.12191","article-title":"Adjunctive Role of MMP-9 Inhibition Along With Conventional Anti-Tubercular Drugs Against Experimental Tuberculous Meningitis","volume":"97","author":"Majeed","year":"2016","journal-title":"Int J Exp Pathol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02370","article-title":"Inhibition of Tissue Matrix Metalloproteinases Interferes With Mycobacterium Tuberculosis-Induced Granuloma Formation and Reduces Bacterial Load in a Human Lung Tissue Model","volume":"8","author":"Parasa","year":"2017","journal-title":"Front Microbiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2010.12.003","article-title":"Clinical Studies on the Management of Periodontal Diseases Utilizing Subantimicrobial Dose Doxycycline (SDD)","volume":"63","author":"Caton","year":"2011","journal-title":"Pharmacol Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141895","article-title":"Doxycycline Host-Directed Therapy in Human Pulmonary Tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","article-title":"Tuberculosis, Pulmonary Cavitation, and Matrix Metalloproteinases","volume":"190","author":"Ong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy373","article-title":"Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology","volume":"219","author":"Ordonez","year":"2019","journal-title":"J Infect Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4390","article-title":"Is There New Hope for Therapeutic Matrix Metalloproteinase Inhibition","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aav8424","article-title":"Pathogen-Driven Vascularization","volume":"11","author":"VanHook","year":"2018","journal-title":"Sci Signaling"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nature13967","article-title":"Interception of Host Angiogenic Signalling Limits Mycobacterial Growth","volume":"517","author":"Oehlers","year":"2015","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.celrep.2019.04.072","article-title":"VEGF-A From Granuloma Macrophages Regulates Granulomatous Inflammation by a Non-Angiogenic Pathway During Mycobacterial Infection","volume":"27","author":"Harding","year":"2019","journal-title":"Cell Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.chom.2018.09.004","article-title":"Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth Through Vegf Signaling","volume":"24","author":"Walton","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.09.016","article-title":"Hijacking Host Angiogenesis to Drive Mycobacterial Growth","volume":"24","author":"Uusi-M\u00e4kel\u00e4","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep33162","article-title":"Mycobacterium Tuberculosis Exploits the Formation of New Blood Vessels for its Dissemination","volume":"6","author":"Polena","year":"2016","journal-title":"Sci Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.6.2156","article-title":"Vascular Endothelial Growth Factor Levels in Active Pulmonary Tuberculosis","volume":"125","author":"Alatas","year":"2004","journal-title":"Chest"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.3.9911010","article-title":"Increased Serum Level of Vascular Endothelial Growth Factor in Pulmonary Tuberculosis","volume":"162","author":"Matsuyama","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"852183","DOI":"10.1155\/2012\/852183","article-title":"Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability","volume":"2012","author":"Kimoto","year":"2012","journal-title":"J Ophthalmol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular Endothelial Growth Factor and its Receptor System: Physiological Functions in Angiogenesis and Pathological Roles in Various Diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J Biochem"},{"key":"B84","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12348-016-0112-1","article-title":"Bevacizumab for Paradoxical Worsening Treatment Adjunct in HIV Patient With Choroidal Tuberculoma","volume":"6","author":"Jain","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"B85","first-page":"8","article-title":"Clinical Use of Bevacizumab in Treating Refractory Glaucoma","volume":"8","author":"Popescu","year":"2015","journal-title":"J Med Life"},{"key":"B86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12886-020-01504-y","article-title":"Concurrent Tuberculous Chorioretinitis With Choroidal Neovascularization and Tuberculous Meningitis: A Case Report","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2017.10.25","article-title":"Intravitreal Bevacizumab in Treatment of Retinal Neovascularization From Tuberculous Retinal Vasculitis","volume":"10","author":"Sriboonnark","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2016.12.025","article-title":"Choroidal Neovascularization Secondary to Tuberculosis: Presentation and Management","volume":"5","author":"Lee Kim","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0465","article-title":"Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor","volume":"20","author":"Zhao","year":"2015","journal-title":"Oncologist"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8124","article-title":"The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis","volume":"34","author":"Amaral","year":"2021","journal-title":"Antioxid Redox Signaling"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1231-1234.2000","article-title":"Transient Loss of Resistance to Pulmonary Tuberculosis in P47 Phox\u2013\/\u2013 Mice","volume":"68","author":"Cooper","year":"2000","journal-title":"Infect Immun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00105","article-title":"The Response of Mycobacterium Tuberculosis to Reactive Oxygen and Nitrogen Species","volume":"2","author":"Voskuil","year":"2011","journal-title":"Front Microbiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/antiox10020313","article-title":"Functions of ROS in Macrophages and Antimicrobial Immunity","volume":"10","author":"Herb","year":"2021","journal-title":"Antioxidants"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01481-08","article-title":"Protection of Mycobacterium Tuberculosis From Reactive Oxygen Species Conferred by the Mel2 Locus Impacts Persistence and Dissemination","volume":"77","author":"Cirillo","year":"2009","journal-title":"Infect Immun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700424","article-title":"Update of Antitubercular Prodrugs From a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance","volume":"12","author":"Laborde","year":"2017","journal-title":"ChemMedChem"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7695364","article-title":"Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis","volume":"2018","author":"Shastri","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6198.1097","article-title":"Intravenous N-Acetylcystine: The Treatment of Choice for Paracetamol Poisoning","volume":"2","author":"Prescott","year":"1979","journal-title":"Br Med J"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8050111","article-title":"Medical and Dietary Uses of N-Acetylcysteine","volume":"8","author":"Salamon","year":"2019","journal-title":"Antioxid (Basel)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2007.04.005","article-title":"And Herzenberg LA. N-Acetylcysteine\u2013a Safe Antidote for Cysteine\/Glutathione Deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"5907839","DOI":"10.1155\/2020\/5907839","article-title":"N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis","volume":"2020","author":"Ejigu","year":"2020","journal-title":"Tuberc Res Treat"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e28378","DOI":"10.1371\/journal.pone.0028378","article-title":"Glutathione and Adaptive Immune Responses Against Mycobacterium Tuberculosis Infection in Healthy and HIV Infected Individuals","volume":"6","author":"Guerra","year":"2011","journal-title":"PloS One"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2007.09.002","article-title":"Glutathione Levels and Immune Responses in Tuberculosis Patients","volume":"44","author":"Venketaraman","year":"2008","journal-title":"Microb Pathog"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.210450","article-title":"N-Acetylcysteine as an Add-on to Directly Observed Therapy Short-I Therapy in Fresh Pulmonary Tuberculosis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study","volume":"8","author":"Mahakalkar","year":"2017","journal-title":"Perspect Clin Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1086\/302517","article-title":"Structural Deficiencies in Granuloma Formation in TNF Gene-Targeted Mice Underlie the Heightened Susceptibility to Aerosol Mycobacterium Tuberculosis Infection, Which is Not Compensated for by Lymphotoxin","volume":"162","author":"Bean","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-7-125","article-title":"Role of Tnf\u03b1 in Pulmonary Pathophysiology","volume":"7","author":"Mukhopadhyay","year":"2006","journal-title":"Respir Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.12.017","article-title":"Thalidomide Analogues: Tumor Necrosis Factor-Alpha Inhibitors and Their Evaluation as Anti-Inflammatory Agents","volume":"83","author":"Casal","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401576","article-title":"Thalidomide Treatment Reduces Tumor Necrosis Factor \u03b1 Production and Enhances Weight Gain in Patients With Pulmonary Tuberculosis","volume":"1","author":"Tramontana","year":"1995","journal-title":"Mol Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1826","article-title":"Thalidomide Use for Complicated Central Nervous System Tuberculosis in Children: Insights From an Observational Cohort","volume":"72","author":"van Toorn","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1887-1895.2002","article-title":"Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis","volume":"46","author":"Tsenova","year":"2002","journal-title":"Antimicrobial Agents Chemother"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1086\/515327","article-title":"A Combination of Thalidomide Plus Antibiotics Protects Rabbits From Mycobacterial Meningitis-Associated Death","volume":"177","author":"Tsenova","year":"1998","journal-title":"J Infect Dis"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767080-00011","article-title":"Etanercept","volume":"67","author":"Dhillon","year":"2007","journal-title":"Drugs"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh567","article-title":"TNF-Blocking Agents and Tuberculosis: New Drugs Illuminate an Old Topic","volume":"44","author":"Keane","year":"2005","journal-title":"Rheumatology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04866-x","article-title":"Incidence of Tuberculosis in Patients Receiving Anti-TNF Therapy for Rheumatic Diseases: A Systematic Review","volume":"39","author":"Sartori","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15450.x","article-title":"Evidence That Cyclic AMP Phosphodiesterase Inhibitors Suppress Tnf\u03b1 Generation From Human Monocytes by Interacting With a \u2018Low-Affinity\u2019phosphodiesterase 4 Conformer","volume":"118","author":"Souness","year":"1996","journal-title":"Br J Pharmacol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706495","article-title":"Phosphodiesterase Inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"Br J Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957060-00015","article-title":"Sildenafil","volume":"57","author":"Langtry","year":"1999","journal-title":"Drugs"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615863","article-title":"Antiplatelet Therapy Using Cilostazol, a Specific PDE3 Inhibitor","volume":"82","author":"Ikeda","year":"1999","journal-title":"Thromb Haemost"},{"key":"B118","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1753465812466167","article-title":"Efficacy and Safety of Roflumilast in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis","volume":"7","author":"Oba","year":"2013","journal-title":"Ther Adv Respir Dis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02145-15","article-title":"Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis","volume":"59","author":"Maiga","year":"2015","journal-title":"Antimicrobial Agents Chemother"},{"key":"B120","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive Host-Directed Therapies for Pulmonary Tuberculosis: A Prospective, Open-Label, Phase 2, Randomised Controlled Trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.currproblcancer.2013.06.001","article-title":"US FDA Approved Oral Kinase Inhibitors for the Treatment of Malignancies","volume":"37","author":"Jeong","year":"2013","journal-title":"Curr Probl Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.09.010","article-title":"Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets Against Tuberculosis","volume":"10","author":"Napier","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201538","article-title":"Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium Tuberculosis in Human Macrophages","volume":"189","author":"Bruns","year":"2012","journal-title":"J Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-4-303","article-title":"FDA Drug Approval Summary: Gefitinib (ZD1839)(Iressa\u00ae) Tablets","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e1003946","DOI":"10.1371\/journal.ppat.1003946","article-title":"Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium Tuberculosis Growth","volume":"10","author":"Stanley","year":"2014","journal-title":"PloS Pathog"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e741","DOI":"10.1016\/S2665-9913(20)30384-2","article-title":"Tofacitinib Approved for Arthritis Treatment in Children","volume":"2","author":"Owens","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.07.014","article-title":"Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis","volume":"2","author":"Maiga","year":"2015","journal-title":"EBioMedicine"},{"key":"B128","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4103\/CRST.CRST_234_20","article-title":"Ibrutinib: A Narrative Drug Review","volume":"3","author":"Munot","year":"2020","journal-title":"Cancer Res Stat Treat"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.003","article-title":"Ibrutinib Suppresses Intracellular Mycobacterium Tuberculosis Growth by Inducing Macrophage Autophagy","volume":"80","author":"Hu","year":"2020","journal-title":"J Infect"},{"key":"B130","doi-asserted-by":"publisher","first-page":"a018481","DOI":"10.1101\/cshperspect.a018481","article-title":"Autophagy in Tuberculosis","volume":"4","author":"Deretic","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1210500109","article-title":"Autophagy Protects Against Active Tuberculosis by Suppressing Bacterial Burden and Inflammation","volume":"109","author":"Castillo","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2018.1536598","article-title":"Autophagy: A New Strategy for Host-Directed Therapy of Tuberculosis","volume":"10","author":"Paik","year":"2019","journal-title":"Virulence"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2014.2745","article-title":"Autophagy in the Fight Against Tuberculosis","volume":"34","author":"Bento","year":"2015","journal-title":"DNA Cell Biol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0383OC","article-title":"Loperamide Restricts Intracellular Growth of Mycobacterium Tuberculosis in Lung Macrophages","volume":"55","author":"Juarez","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2020.10.018","article-title":"Current Role of Carbamazepine and Oxcarbazepine in the Management of Epilepsy","volume":"83","author":"Beydoun","year":"2020","journal-title":"Seizure"},{"key":"B136","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/hup.990","article-title":"Comparison of Carbamazepine and Lithium in Treatment of Bipolar Disorder: A Systematic Review of Randomized Controlled Trials","volume":"24","author":"Ceron-Litvoc","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","article-title":"Ibuprofen: Pharmacology, Efficacy and Safety","volume":"17","author":"Rainsford","year":"2009","journal-title":"Inflammopharmacology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)07087-6","article-title":"One Hundred Years of Aspirin","volume":"350","author":"Jack","year":"1997","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl486","article-title":"Aspirin and Ibuprofen Enhance Pyrazinamide Treatment of Murine Tuberculosis","volume":"59","author":"Byrne","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01145-06","article-title":"Aspirin Antagonism in Isoniazid Treatment of Tuberculosis in Mice","volume":"51","author":"Byrne","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e33478","DOI":"10.7554\/eLife.33478","article-title":"A Randomised Double Blind Placebo Controlled Phase 2 Trial of Adjunctive Aspirin for Tuberculous Meningitis in HIV-Uninfected Adults","volume":"7","author":"Mai","year":"2018","journal-title":"Elife"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002966.pub3","article-title":"Metformin Monotherapy for Type 2 Diabetes Mellitus","author":"Saenz","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-73212-y","article-title":"Metformin Enhances Protection in Guinea Pigs Chronically Infected With Mycobacterium Tuberculosis","volume":"10","author":"Frenkel","year":"2020","journal-title":"Sci Rep"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4548-4","article-title":"Impact of Metformin on the Risk and Treatment Outcomes of Tuberculosis in Diabetics: A Systematic Review","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02786-y","article-title":"Impacts of Metformin on Tuberculosis Incidence and Clinical Outcomes in Patients With Diabetes: A Systematic Review and Meta-Analysis","volume":"76","author":"Zhang","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"B146","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-030-56905-1_7","article-title":"Metformin: A Leading HDT Candidate for TB","volume-title":"Advances in Host-Directed Therapies Against Tuberculosis","author":"Singhal","year":"2021"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500931","article-title":"Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated With Late-Stage Tuberculosis in C3HeB\/FeJ Mice","volume":"196","author":"Reeme","year":"2016","journal-title":"J Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2020.100174","article-title":"Clinical Efficacy of Vitamin D Supplementation on Pulmonary TB Patients: The Evidence of Clinical Trials","volume":"20","author":"Karbalaei","year":"2020","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0185OC","article-title":"Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis","volume":"56","author":"Mourik","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis778","article-title":"Granuloma Correlates of Protection Against Tuberculosis and Mechanisms of Immune Modulation by Mycobacterium Tuberculosis","volume":"207","author":"Mehra","year":"2013","journal-title":"J Infect Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3030703","article-title":"The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity","volume":"3","author":"Mbongue","year":"2015","journal-title":"Vaccines"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep18176","article-title":"Infection With Mycobacterium Tuberculosis Induces the Warburg Effect in Mouse Lungs","volume":"5","author":"Shi","year":"2015","journal-title":"Sci Rep"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.9b00868","article-title":"Comprehensive Examination of the Mouse Lung Metabolome Following Mycobacterium Tuberculosis Infection Using a Multiplatform Mass Spectrometry Approach","volume":"19","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"J Proteome Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92973","article-title":"Interleukin-17 Limits Hypoxia-Inducible Factor 1\u03b1 and Development of Hypoxic Granulomas During Tuberculosis","volume":"2","author":"Domingo-Gonzalez","year":"2017","journal-title":"JCI Insight"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.14362","article-title":"Mycobacterium Tuberculosis Requires Glyoxylate Shunt and Reverse Methylcitrate Cycle for Lactate and Pyruvate Metabolism","volume":"112","author":"Serafini","year":"2019","journal-title":"Mol Microbiol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05916-7","article-title":"Lactate Oxidation Facilitates Growth of Mycobacterium Tuberculosis in Human Macrophages","volume":"7","author":"Billig","year":"2017","journal-title":"Sci Rep"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31812e00a1","article-title":"Reactivation of Pulmonary Tuberculosis in a Patient With Rheumatoid Arthritis During Treatment With IL-1 Receptor Antagonists (Anakinra)","volume":"13","author":"Settas","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201405-0828OC","article-title":"Lung-Residing Myeloid-Derived Suppressors Display Dual Functionality in Murine Pulmonary Tuberculosis","volume":"190","author":"Knaul","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased Frequency of Myeloid-Derived Suppressor Cells During Active Tuberculosis and After Recent Mycobacterium Tuberculosis Infection Suppresses T-Cell Function","volume":"188","author":"du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00332","article-title":"Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis","volume":"8","author":"Du Plessis","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62388-0","article-title":"Statins: New American Guidelines for Prevention of Cardiovascular Disease","volume":"382","author":"Ridker","year":"2013","journal-title":"Lancet"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The Discovery and Development of HMG-CoA Reductase Inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J Lipid Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0094-3","article-title":"Statins: A Viable Candidate for Host-Directed Therapy Against Infectious Diseases","volume":"19","author":"Parihar","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1917","article-title":"Host-Directed Drug Therapy for Tuberculosis","volume":"11","author":"Guler","year":"2015","journal-title":"Nat Chem Biol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw014","article-title":"Statin Adjunctive Therapy Shortens the Duration of TB Treatment in Mice","volume":"71","author":"Dutta","year":"2016","journal-title":"J Antimicrobial Chemother"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku166","article-title":"Simvastatin Increases the In Vivo Activity of the First-Line Tuberculosis Regimen","volume":"69","author":"Skerry","year":"2014","journal-title":"J\u00a0Antimicrobial Chemother"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207052","article-title":"Statin Treatment is Associated With a Decreased Risk of Active Tuberculosis: An Analysis of a Nationally Representative Cohort","volume":"71","author":"Lai","year":"2016","journal-title":"Thorax"},{"key":"B168","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.chest.2017.04.170","article-title":"Statin Use is Associated With a Lower Risk of TB","volume":"152","author":"Su","year":"2017","journal-title":"Chest"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160511369","article-title":"Statin, Calcium Channel Blocker and Beta Blocker Therapy may Decrease the Incidence of Tuberculosis Infection in Elderly Taiwanese Patients With Type 2 Diabetes","volume":"16","author":"Lee","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00121","article-title":"Statin Use may be Associated With Reduced Active Tuberculosis Infection: A Meta-Analysis of Observational Studies","volume":"7","author":"Li","year":"2020","journal-title":"Front Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01790","article-title":"Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism","volume":"11","author":"Kim","year":"2020","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.242","article-title":"The Causes, Treatment, and Outcome of Pulmonary Hypertension in Africa: Insights From the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry","volume":"221","author":"Thienemann","year":"2016","journal-title":"Int J Cardiol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"e0141230","DOI":"10.1371\/journal.pone.0141230","article-title":"Pulmonary Impairment in Tuberculosis Survivors: The Korean National Health and Nutrition Examination Survey 2008-2012","volume":"10","author":"Jung","year":"2015","journal-title":"PloS One"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02325-2014","article-title":"Tuberculosis Associates With Both Airflow Obstruction and Low Lung Function: BOLD Results","volume":"46","author":"Amaral","year":"2015","journal-title":"Eur Respir J"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12256","article-title":"Inflammation and Tuberculosis: Host-Directed Therapies","volume":"277","author":"Zumla","year":"2015","journal-title":"J Intern Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660916","article-title":"Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis","volume":"12","author":"Krug","year":"2021","journal-title":"Front Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"ftaa015","DOI":"10.1093\/femspd\/ftaa015","article-title":"Host-Directed Therapies Targeting the Tuberculosis Granuloma Stroma","volume":"78","author":"Hortle","year":"2020","journal-title":"Pathog Dis"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1002\/path.5407","article-title":"Effects of Host-Directed Therapies on the Pathology of Tuberculosis","volume":"250","author":"Tsenova","year":"2020","journal-title":"J Pathol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","article-title":"Therapeutic Host-Directed Strategies to Improve Outcome in Tuberculosis","volume":"13","author":"Young","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B180","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-015-0537-x","article-title":"Host-Directed Therapy Targeting the Mycobacterium Tuberculosis Granuloma: A Review","volume-title":"Semin Immunopathol","author":"Kiran","year":"2016"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00434","article-title":"Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis","volume":"7","author":"Ndlovu","year":"2016","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.733853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:54:14Z","timestamp":1634770454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.733853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":181,"alternative-id":["10.3389\/fimmu.2021.733853"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.733853","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"article-number":"733853"}}